Persistent increased risk for thymoma in myasthenia gravis associated with myositis [1]

Muscle and Nerve

Volumn 34, Issue 2, 2006, Pages 251-252

  Hengstman, Gerald J D ^a   Drost, Gea ^a   Wagenaar, Michiel ^a   Van Engelen, Baziel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN;

CANCER RADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMOMYOSITIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LETTER; MYASTHENIA GRAVIS; MYOSITIS; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; THYMECTOMY; THYMOMA;

ADULT; FEMALE; HUMANS; MYASTHENIA GRAVIS; MYOSITIS; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 33746740458     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20546     Document Type: Letter

References (7)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
2. Evoli A, Minisci C, Di Schino C, Marsili F, Punzi C, Batocchi AP, et al. Thymoma in patients with MG. Characteristics and long-term outcome. Neurology 2002;59:1844-1850.
3. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004;29:484-505.
4. Keesey J, Bein M, Mink J, Sample F, Sarti D, Mulder D, et al. Detection of thymoma in myasthenia gravis. Neurology 1980;30:233-239.
5. Oosterhuis HJGH. Diagnosis and differential diagnosis. In: DeBaets MH, Oosterhuis HJGH, editors. Myasthenia gravis. Boca Raton, FL: CRC Press; 1993. p 203-234.
6. Rosenberg CA. Thymic neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott; 1992. p 763-770.
7. Van de Warrenburg BPC, Hengstman GJD, Vos PE, Boerman RH, Ter Laak HJ, Van Engelen BGM. Concomitant dermatomyositis and myasthenia gravis presenting with respiratory insufficiency. Muscle Nerve 2002;25:293-296.